Page last updated: 2024-10-30

lofepramine and Depressive Disorder, Major

lofepramine has been researched along with Depressive Disorder, Major in 1 studies

Lofepramine: A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, RS1

Other Studies

1 other study available for lofepramine and Depressive Disorder, Major

ArticleYear
Dose of tricyclic antidepressants in elderly patients.
    JAMA, 1999, May-26, Volume: 281, Issue:20

    Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Humans; Lofepramine; Nortriptyli

1999